Literature DB >> 20592731

Human papillomavirus oncoproteins: pathways to transformation.

Cary A Moody1, Laimonis A Laimins.   

Abstract

An association between human papillomavirus (HPV) infection and the development of cervical cancer was initially reported over 30 years ago, and today there is overwhelming evidence that certain subtypes of HPV are the causative agents of these malignancies. The p53 and retinoblastoma proteins are well-characterized targets of the HPV E6 and E7 oncoproteins, but recent studies have shown that the alteration of additional pathways are equally important for transformation. These additional factors are crucial regulators of cell cycle progression, telomere maintenance, apoptosis and chromosomal stability. Understanding how HPV oncoproteins modify these activities provides novel insights into the basic mechanisms of oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592731     DOI: 10.1038/nrc2886

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  148 in total

Review 1.  Chromatin remodeling and Rb activity.

Authors:  J W Harbour; D C Dean
Journal:  Curr Opin Cell Biol       Date:  2000-12       Impact factor: 8.382

Review 2.  Mechanisms of cell transformation by papillomavirus E5 proteins.

Authors:  D DiMaio; D Mattoon
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

Review 3.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

4.  Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells.

Authors:  Y Liu; J J Chen; Q Gao; S Dalal; Y Hong; C P Mansur; V Band; E J Androphy
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene.

Authors:  M Dürst; D Gallahan; G Jay; J S Rhim
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

6.  Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.

Authors:  Wanxia He; Doug Staples; Clark Smith; Chris Fisher
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells.

Authors:  S Jeon; B L Allen-Hoffmann; P F Lambert
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Human papillomavirus type 16 E7 oncoprotein associates with E2F6.

Authors:  Margaret E McLaughlin-Drubin; Kyung-Won Huh; Karl Münger
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

9.  Molecular pathways executing the "trophic sentinel" response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation.

Authors:  Alexandra Eichten; Debrah S Rud; Miranda Grace; Siribang-On Piboonniyom; Valerie Zacny; Karl Münger
Journal:  Virology       Date:  2004-02-05       Impact factor: 3.616

10.  The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells.

Authors:  G F Valle; L Banks
Journal:  J Gen Virol       Date:  1995-05       Impact factor: 3.891

View more
  624 in total

Review 1.  [HPV-associated squamous cell carcinogenesis].

Authors:  G Assmann; K Sotlar
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

Review 2.  [Malignancy potential of precursor lesions: determination using molecular markers].

Authors:  A Jung
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

Review 3.  Centrosome amplification: a suspect in breast cancer and racial disparities.

Authors:  Angela Ogden; Padmashree C G Rida; Ritu Aneja
Journal:  Endocr Relat Cancer       Date:  2017-05-17       Impact factor: 5.678

Review 4.  Exploiting the curative potential of adoptive T-cell therapy for cancer.

Authors:  Christian S Hinrichs; Steven A Rosenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 5.  Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.

Authors:  Megan A Clarke; Nicolas Wentzensen; Lisa Mirabello; Arpita Ghosh; Sholom Wacholder; Ariana Harari; Attila Lorincz; Mark Schiffman; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

6.  Evidence of association of human papillomavirus with prognosis worsening in glioblastoma multiforme.

Authors:  Michele Vidone; Federica Alessandrini; Gianluca Marucci; Anna Farnedi; Dario de Biase; Fulvio Ricceri; Claudia Calabrese; Ivana Kurelac; Anna Maria Porcelli; Monica Cricca; Giuseppe Gasparre
Journal:  Neuro Oncol       Date:  2013-11-26       Impact factor: 12.300

7.  Supervillin-mediated suppression of p53 protein enhances cell survival.

Authors:  Zhiyou Fang; Elizabeth J Luna
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

8.  17β-hydroxysteroid dehydrogenase type Gene 1937 A > G Polymorphism as a Risk Factor for Cervical Cancer Progression in the Polish Population.

Authors:  Anna Lutkowska; Andrzej Roszak; Pawel P Jagodziński
Journal:  Pathol Oncol Res       Date:  2016-08-29       Impact factor: 3.201

9.  Ad E1A 243R oncoprotein promotes association of proto-oncogene product MYC with the NuA4/Tip60 complex via the E1A N-terminal repression domain.

Authors:  Ling-Jun Zhao; Paul M Loewenstein; Maurice Green
Journal:  Virology       Date:  2016-09-22       Impact factor: 3.616

Review 10.  Role of plasmonics in detection of deadliest viruses: a review.

Authors:  Foozieh Sohrabi; Sajede Saeidifard; Masih Ghasemi; Tannaz Asadishad; Seyedeh Mehri Hamidi; Seyed Masoud Hosseini
Journal:  Eur Phys J Plus       Date:  2021-06-20       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.